ChrysCapital is set to acquire a 20-25% stake in Linux Laboratories, a CNS-focused pharmaceutical company in Chennai, for approximately $60-65 million, marking a significant investment in India’s ...
A new study suggests that Tylenol usage during pregnancy may impact the development of female reproductive organs in ...
Sandoz, the Swiss drugmaker, aims to double its annual net sales by 2035, focusing on biosimilars. The company plans to ...
Bristol Myers Squibb announces its experimental cell therapy, arlocabtagene autoleucel, met key goals in a mid-stage trial ...
Lupin Limited has received marketing approval for its biosimilar pegfilgrastim in India, aiding in chemotherapy recovery. The ...
The US health department has officially appointed Michael Davis and Karim Mikhail as permanent heads of the FDA’s drug and ...
Amgen's Imdelltra combined with AstraZeneca's Imfinzi shows significant improvement in overall and progression-free survival ...
Sun Pharmaceutical Industries has secured investment-grade ratings from Moody's and S&P for its proposed $11.75 billion ...
Novartis' cholesterol drug pelacarsen fails to reduce heart attack and stroke risk in late-stage study, impacting investor ...
Novo Nordisk announces the termination of two heart drug trials for ziltivekimab, casting doubt on its diversification ...
Biocon has signed a significant 10-year contract to supply pertuzumab, a breast cancer drug, in Brazil, emphasizing its ...
New Delhi: More than 60% of the 8,500 registered small and medium pharmaceutical units in India may be forced to shut shop by the end of this month for failing to comply with the guidelines on good ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results